UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
                       PURSUANT TO SECTION 13 OR 15 (d) OF
                       THE SECURITIES EXCHANGE ACT OF 1934

       DATE OF REPORT (Date of earliest event reported): January 29, 2002

                        COMMISSION FILE NUMBER 333-92383

                 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
             (Exact Name of Registrant as specified in its Charter)

                   DELAWARE                     06-1397316
          (State of Incorporation) (I.R.S. Employer Identification No.)

             251 BALLARDVALE STREET, WILMINGTON, MASSACHUSETTS 01887
               (Address of Principal Executive Offices) (Zip Code)

                                  978-658-6000
              (Registrant's Telephone Number, Including Area Code)









                              ITEM 5. OTHER EVENTS

On January 29, 2002, the Registrant issued a press release announcing receipt of
requisite consents from holders of its outstanding 13.50% Senior Subordinated
Notes due 2009. A copy of the press release is filed with this Form 8-K as
Exhibit 99.1.



EXHIBIT 99.1

Press Release dated January 29, 2002

                                   SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended,
we have duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.

                               CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Dated: January 30, 2002

                                BY: /s/ Rushna T. Heneghan,
                                ----------------------------------

                                Rushna T. Heneghan,
                                Corporate Counsel and Assistant Secretary